Structural and biological characterization of highly purified hepta-acyl lipid A present in the lipopolysaccharide of the Salmonella enterica sv. Minnesota Re deep rough mutant strain R595

Journal of Endotoxin Research

Volumn 8, Issue 5, 2002, Pages 343-356

  Janusch, Holger ^a   Brecker, Lothar ^a   Lindner, Buko ^a   Alexander, Christian ^a   Gronow, Sabine ^a   Heine, Holger ^a   Ulmer, Artur J ^a   Rietschel, Ernst T ^a   Zähringer, Ulrich ^a  

^a RESEARCH CENTER BORSTEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPID A; TUMOR NECROSIS FACTOR ALPHA;

BACTERIAL STRAIN; BACTERIUM MUTANT; BONE MARROW CELL; CELL ISOLATION; CELL STIMULATION; CELL STRAIN U937; CONTROLLED STUDY; CYTOTOXICITY TEST; ESCHERICHIA COLI; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MACROPHAGE; MASS SPECTROMETRY; MONONUCLEAR CELL; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROTEIN ANALYSIS; PROTEIN PURIFICATION; PROTEIN STRUCTURE; REVIEW; SALMONELLA ENTERICA; SALMONELLA MINNESOTA; THIN LAYER CHROMATOGRAPHY;

CELL LINE; CELLS, CULTURED; CHROMATOGRAPHY, THIN LAYER; HUMANS; IMMUNOBLOTTING; INTERLEUKIN-1; INTERLEUKIN-6; LIPID A; LIPOPOLYSACCHARIDES; MACROPHAGES; MONOCYTES; MUTATION; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; SALMONELLA ENTERICA; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUMOR NECROSIS FACTOR-ALPHA;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; SALMONELLA ENTERICA; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR MINNESOTA;

EID: 0036449405     PISSN: 09680519     EISSN: None     Source Type: Journal    
DOI: 10.1179/096805102125000678     Document Type: Review

References (37)

1. Wollenweber H-W, Broady KW, Lüderitz O, Rietschel ET. The chemical structure of lipid A: demonstration of amide-linked 3-acyloxyacyl residues in Salmonella minnesota Re lipopolysaccharide. Eur J Biochem 1982; 124: 191-198
2. Qureshi N, Mascagni P, Ribi EE, Takayama K. Monophosphoryl lipid A obtained from the lipopolysaccharides of Salmonella minnesota R595. Purification of the dimethyl derivative by high performance liquid chromatography and complete structural determination. J Biol Chem 1985; 260: 5271-5278
3. Galanos C, Lüderitz O, Freudenberg MA et al. Biological activity of synthetic heptaacyl lipid A representing a component of Salmonella minnesota R595 lipid A. Eur J Biochem 1986; 160: 55-59
4. Zhou ZM, Ribeiro AA, Raetz CRH. High-resolution NMR spectroscopy of lipid A molecules containing 4-amino-4-deoxy-L-arabinose and phosphoethanolamine substituents. J Biol Chem 2000; 275: 13542-13551
5. Feist W, Ulmer AJ, Musehold J, Brade H, Kusumoto S, Flad H-D. Induction of tumor necrosis factor alpha-release by lipopolysaccharide and defined lipopolysaccharide partial structures. Immunobiology 1989; 179: 293-307
6. Loppnow H, Brade H, Dürrbaum-Landmann I et al. Interleukin 1 induction-capacity of defined lipopolysaccharide partial structures. J Immunol 1989; 142: 3229-3238
7. Kanegasaki S, Tanamoto K-I, Yasuda T et al. Structure-activity relationship of lipid A: comparison of biological activities of natural and synthetic lipid As with different fatty acid compositions. J Biochem (Tokyo) 1986; 99: 1203-1210
8. Kasai N, Arata S, Mashimo J-I et al. Synthetic Salmonella-type lipid A antigen with high serological specificity. Infect Immun 1986; 51: 43-48
9. Loppnow H, Brade L, Brade H et al. Induction of human interleukin 1 by bacterial and synthetic lipid A. Eur J Immunol 1986; 16: 1263-1267
10. Ulmer AJ, Heine H, Feist W et al. Biological activity of lipid A partial structures. Prog Clin Biol Res 1994; 388: 71-83
11. Tanamoto K-I, Azumi S. Salmonella-type heptaacylated lipid A is inactive and acts as an antagonist of lipopolysaccharide action on human line cells. J Immunol 2000; 164: 3149-3156
12. Poltorak A, Ricciardi-Castagnoli P, Citterio S, Beutler B. Physical contact between lipopolysaccharide and Toll-like receptor 4 revealed by genetic complementation. Proc Natl Acad Sci USA 2000; 97: 2163-2167
13. Lien E, Means TK, Heine H et al. Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide. J Clin Invest 2000; 105: 497-504
14. Lien E, Chow JC, Hawkins LD et al. A novel synthetic acyclic lipid A-like agonist activates cells via the lipopolysaccharide/Toll-like receptor 4 signaling pathway. J Biol Chem 2001; 276: 1873-1880
15. Akashi S, Nagai Y, Haysahi S, Kimoto M, Miyake K. Human MD-2 confers on mouse Toll-like receptor 4 species-specific lipopolysaccharide recognition. Int Immunol 2001; 13: 1595-1599
16. Schlecht S. Growth and lipopolysaccharide content of Salmonellae grown in submersed cultures according to the batch-method. 2. Communication: Influence of growth on lipopolysaccharide synthesis. Zbl Bakt Hyg, I Abt Orig 1975; A 232: 61-72
17. Galanos C, Lüderitz O, Westphal O. A new method for the extraction of R lipopolysaccharides. Eur J Biochem 1969; 9: 245-249
18. Strominger JL, Park JT, Thompson RE. Composition of the cell wall of Staphylococcus aureus: its relation to the mechanism of action of penicillin. J Biol Chem 1959; 234: 3263-3267
19. Lowry OH, Roberts NR, Leiner KY, Wu ML, Farr AL. The quantitative histochemistry of brain. J Biol Chem 1954; 207: 1-17
20. Gronow S, Brabetz W, Brade H. Comparative functional characterization in vitro of heptosyltransferase I (WaaC) and II (WaaF) from Escherichia coli. Eur J Biochem 2000; 267: 6602-6611
21. Kuhn H-M, Brade L, Appelmelk BJ, Kusumoto S, Rietschel ET, Brade H. Characterization of the epitope specificity of murine monoclonal antibodies directed against lipid A. Infect Immun 1992; 60: 2201-2210
22. Feist W, Ulmer AJ, Wang M-H et al. Modulation of lipopolysaccharide-induced production of tumor necrosis factor, interleukin 1, and interleukin 6 by synthetic precursor Ia of lipid A. FEMS Microbiol Immunol 1992; 89: 73-90
23. Zähringer U, Salvetzki R, Wagner F, Lindner B, Ulmer AJ. Structural and biological characterisation of a novel tetra-acyl lipid A from Escherichia coli F515 lipopolysaccharide acting as endotoxin antagonist in human monocytes. J Endotoxin Res 2001; 7: 133-146
24. Lindner B. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry of lipopolysaccharides. In: Holst O. (ed) Bacterial Toxins. Methods and Protocols. Totowa, NJ: Humana, 2000; 311-325
25. Ribeiro AA, Zhou ZM, Raetz CRH. Multi-dimensional NMR structural analyses of purified lipid X and lipid A (endotoxin). Magn Reson Chem 1999; 37: 620-630
26. Wang Y, Hollingsworth RI. A solvent system for the high-resolution proton nuclear magnetic resonance spectroscopy of membrane lipids. Anal Biochem 1995; 225: 242-251
27. Fukuoka S, Brandenburg K, Müller M, Lindner B, Koch MHJ, Seydel U. Physico-chemical analysis of lipid A fractions of lipopolysaccharide from Erwinia carotovora in relation to bioactivity. Biochim Biophys Acta 2001; 1510: 185-197
28. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 1990; 249: 1431-1433
29. Hailman E, Lichenstein HS, Wurfel MM et al. Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14. J Exp Med 1994; 179: 269-277
30. Tobias PS, Soldau K, Gegner JA, Mintz D, Ulevitch RJ. Lipopolysaccharide binding protein-mediated complexation of lipopolysaccharide with soluble CD14. J Biol Chem 1995; 270: 10482-10488
31. Yu B, Wright SD. Catalytic properties of lipopolysaccharide (LPS) binding protein - transfer of LPS to soluble CD14. J Biol Chem 1996; 271: 4100-4105
32. Delude RL, Savedra Jr R, Zhao HL et al. CD14 enhances cellular responses to endotoxin without imparting ligand-specific recognition. Proc Natl Acad Sci USA 1995; 92: 9288-9292
33. Hoshino K, Takeuchi O, Kawai T et al. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol 1999; 162: 3749-3752
34. Wurfel MM, Monks BG, Ingalls RR et al. Targeted deletion of the lipopolysaccharide (LPS)-binding protein gene leads to profound suppression of LPS responses ex vivo, whereas in vivo responses remain intact. J Exp Med 1997; 186: 2051-2056
35. Gangloff SC, Hijiya N, Haziot A, Goyert SM. Lipopolysaccharide structure influences the macrophage response via CD14-independent and CD14-dependent pathways. Clin Infect Dis 1999; 28: 491-496
36. Shimazu R, Akashi S, Ogata H et al. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J Exp Med 1999; 189: 1777-1782
37. Muroi M, Ohnishi T, Tanamoto KI. MD-2, a novel accessory molecule, is involved in species specific actions of Salmonella lipid A. Infect Immun 2002; 70: 3546-3550